Breaking News, Collaborations & Alliances

EPNextS Group and Frontage Labs Partner to Address ‘Drug Lag’ & ‘Drug Loss’ in Japan

Aim to combine their respective strengths to streamline the drug development process and bring novel treatments to market more efficiently.

Author Image

By: Charlie Sternberg

Associate Editor

EPNextS Group, a Japanese-based provider of clinical trial solutions, and Frontage Laboratories Inc., a US-based full-service contract research organization (CRO), have announced a collaboration aimed at addressing the challenges of “Drug Lag” and “Drug Loss” in Japan.   EPNextS Group and Frontage intend to leverage EPNextS Group’s expertise in clinical trial solutions and Frontage’s extensive experience in early-phase drug development and clinical research ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters